[Drug therapy and prevention of recurrence of supraventricular tachyarrhythmias].
Steinbigler
P
P
Medizinische Klinik I, Ludwig-Maximilians-Universität München.
Haberl
R
R
Steinbeck
G
G
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001283:Atrioventricular Node / Q000187:drug effects / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004562:Electrocardiography / Q000187:drug effects; D006801:Humans; D012008:Recurrence; D013617:Tachycardia, Supraventricular / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants
Medikamentöse Therapie und Rezidivprophylaxe supraventrikulärer Tachyarrhythmien.